Search Prime Grants

U01CA227954

Cooperative Agreement

Overview

Grant Description
Pre-clinical novel radiosensitizer evaluation program for brain tumors.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Place of Performance
Rochester, Minnesota 559050001 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 395% from $596,490 to $2,952,359.
Mayo Clinic was awarded Pre-Clinical Novel Radiosensitizer Evaluation Program for Brain Tumors Cooperative Agreement U01CA227954 worth $2,952,359 from National Cancer Institute in June 2018 with work to be completed primarily in Rochester Minnesota United States. The grant has a duration of 5 years and was awarded through assistance program 93.395 Cancer Treatment Research. The Cooperative Agreement was awarded through grant opportunity Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01).

Status
(Complete)

Last Modified 2/5/24

Period of Performance
6/14/18
Start Date
5/31/23
End Date
100% Complete

Funding Split
$3.0M
Federal Obligation
$0.0
Non-Federal Obligation
$3.0M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U01CA227954

Subgrant Awards

Disclosed subgrants for U01CA227954

Transaction History

Modifications to U01CA227954

Additional Detail

Award ID FAIN
U01CA227954
SAI Number
U01CA227954-2366473154
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
Y2K4F9RPRRG7
Awardee CAGE
5A021
Performance District
MN-01
Senators
Amy Klobuchar
Tina Smith

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $3,520,014 100%
Modified: 2/5/24